Invention Grant
- Patent Title: Method of using time to effect (TTE) to estimate the optimum cryodose to apply to a pulmonary vein
-
Application No.: US15091865Application Date: 2016-04-06
-
Publication No.: US10251692B2Publication Date: 2019-04-09
- Inventor: Jean-Pierre Lalonde
- Applicant: Medtronic CryoCath LP
- Applicant Address: CA Toronto, Ontario
- Assignee: Medtronic CryoCath LP
- Current Assignee: Medtronic CryoCath LP
- Current Assignee Address: CA Toronto, Ontario
- Agency: Christopher & Weisberg, P.A.
- Main IPC: A61B18/02
- IPC: A61B18/02 ; A61B18/00

Abstract:
A system and method for determining the optimum dose of cryotreatment to an area of target tissue to achieve isolation based on the time to effect (TTE). The system may generally include a treatment device, a sensing device, and a processor programmed to calculate the optimum dose of cryotreatment, in seconds, based on TTE. The TTE may be based on electrical signals received by the processor from the sensing device. The processor may be further programmed to automatically terminate a cryoablation procedure when the optimum dose of cryotreatment has elapsed. The optimum dose of cryotreatment may be the time, in seconds, it takes to achieve isolation, which may be the time it takes for an area of tissue to reach approximately −20° C.
Public/Granted literature
- US20170290618A1 METHOD OF USING TIME TO EFFECT (TTE) TO ESTIMATE THE OPTIMUM CRYODOSE TO APPLY TO A PULMONARY VEIN Public/Granted day:2017-10-12
Information query